A Clinical Study of Hyperthyroidism in Children
Key facts
- Where
- Shenyang, ChinaSee the site
Where in China
- Shengjing Hospital Of China Medical UniversityShenyang, ChinaContact: Ying Xin, DoctorTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Shengjing Hospital
- Trial code
- NCT06570967
- Record updated
- 27 August 2024
- Original description
This study intends to conduct a retrospective and prospective study on children with hyperthyroidism, and it is a non-intervention study to collect information on diagnosis and treatment and long-term follow-up of children with hyperthyroidism. To investigate the clinical characteristics, treatment effect, side effects and remission of hyperthyroidism in children, to analyze the predictive factors for the effect of antithyroid drug treatment, remission and recurrence after drug withdrawal, and to explore the risk factors related to the occurrence of antithyroid drug-related adverse reactions.Read full original descriptionShow less
A Retrospective and Prospective Observational Study of Hyperthyroidism in Children
This study intends to conduct a retrospective and prospective study on children with hyperthyroidism, and it is a non-intervention study to collect information on diagnosis and treatment and long-term follow-up of children with hyperthyroidism. To investigate the clinical characteristics, treatment effect, side effects and remission of hyperthyroidism in children, to analyze the predictive factors for the effect of antithyroid drug treatment, remission and recurrence after drug withdrawal, and to explore the risk factors related to the occurrence of antithyroid drug-related adverse reactions.
Inclusion: Age ≤14 years old; Initial diagnosis of hyperthyroidism.
Exclusion: Hyperthyroidism had been treated with medication in other hospitals,; History of autoimmune hepatitis, viral hepatitis, hematological diseases, bone marrow or liver transplantation,; Patients with incomplete clinical data.